Results 1 to 10 of about 40,904 (213)
Archives of Epilepsy, 2023 Epilepsy is a chronic disease caused by an increased excitability of nerve cells in the brain, characterized by two or more unprovoked seizures, which can be attributed to genetic or acquired causes.
Ahmet Eren Seçen +2 more
doaj +3 more sources
Cortisol, interleukins and S100B in delirium in the elderly [PDF]
Brain and Cognition, 2010 In independent studies delirium was associated with higher levels of cortisol, interleukin(IL)s, and S100B. The aim of this study was to simultaneously compare cortisol, IL-6, IL-8, and S100B levels in patients aged 65years and older admitted for hip fracture surgery with and without delirium.
Barbara C Van Munster +2 more
exaly +3 more sources
Comprehensive analysis of the correlations of S100B with hypoxia response and immune infiltration in hepatocellular carcinoma [PDF]
PeerJ, 2022 S100B has been found to be dysregulated in many cancers including hepatocellular carcinoma (HCC). However, the functions of S100B and its underlying mechanisms in HCC remain poorly understood, especially in the tumor microenvironment.
Jia Yan +4 more
doaj +2 more sources
Düzce Tıp Fakültesi Dergisi, 2021 Aim: Autism spectrum disorder is a neurodevelopmental disorder. The S100 calcium binding protein B (S100B) is among the markers of astrocyte activation as well as brain damage. Herein, it was aimed to evaluate S100B levels to determine whether there is a
Özge Demircan +3 more
doaj +1 more source
Serum S100B Levels in Patients with Liver Cirrhosis and Hepatic Encephalopathy
Diagnostics, 2023 Hepatic encephalopathy (HE) is one of the main complications of liver cirrhosis (LC) and is classified into minimal hepatic encephalopathy (MHE) and overt hepatic encephalopathy (overt HE).
Mo-Jong Kim +11 more
doaj +1 more source
Extracranial sources of S100B do not affect serum levels. [PDF]
PLoS ONE, 2010 S100B, established as prevalent protein of the central nervous system, is a peripheral biomarker for blood-brain barrier disruption and often also a marker of brain injury. However, reports of extracranial sources of S100B, especially from adipose tissue,
Nancy Pham +6 more
doaj +1 more source
CRISPR/dCas9-KRAB-Mediated Suppression of S100b Restores p53-Mediated Apoptosis in Melanoma Cells
Cells, 2023 Overexpression of S100B is routinely used for disease-staging and for determining prognostic outcomes in patients with malignant melanoma. Intracellular interactions between S100B and wild-type (WT)-p53 have been demonstrated to limit the availability of
Samrat Roy Choudhury +5 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2021 Objective: This study aimed to clarify the novel role of homeostatic calmodulin S100B and determined whether S100B genetic variants affected atherosclerosis progression in acute myocardial infarction (AMI) patients.Methods: Plasma levels of S100B were ...
Minghui Cheng +6 more
doaj +1 more source
An Interplay of S-Nitrosylation and Metal Ion Binding for Astrocytic S100B Protein. [PDF]
PLoS ONE, 2016 Mammalian S100B protein plays multiple important roles in cellular brain processes. The protein is a clinically used marker for several pathologies including brain injury, neurodegeneration and cancer.
Małgorzata Bajor +5 more
doaj +1 more source
Is peripheral immunity regulated by blood-brain barrier permeability changes? [PDF]
PLoS ONE, 2014 S100B is a reporter of blood-brain barrier (BBB) integrity which appears in blood when the BBB is breached. Circulating S100B derives from either extracranial sources or release into circulation by normal fluctuations in BBB integrity or pathologic BBB ...
Erin Bargerstock +11 more
doaj +1 more source